Is HNR1.SW stock a buy after the CHF 219 surge?

HNR1.SW stock shows value metrics but the surge was on tiny volume. Our grade is B+ (BUY), yet the Meyka 1‑year forecast at CHF 173.34 implies downside. Wait for volume confirmation and clearer earnings data before buying.

What are the key risks for HNR1.SW stock traders?

Key risks for HNR1.SW stock include low liquidity on the SIX, catastrophe loss exposure for reinsurers, and short‑term whipsaws. Use strict stops and limit position size when trading this oversold bounce.

How does valuation look for HNR1.SW stock?

Valuation for HNR1.SW stock appears reasonable: PE **11.72**, EPS **CHF 18.69**, price to book **2.35**, and free cash flow yield near **8.09%**. These metrics suit value and income investors who accept insurance sector risks.

When is the next earnings or event to watch for HNR1.SW stock?

The next listed earnings announcement for HNR1.SW stock is 12 Mar 2026. Traders should watch the report for underwriting results, reserve developments, and outlook that can confirm or reverse the recent bounce.

CH Stocks

HNR1.SW Hannover Rück SE (SIX) jumps to CHF 219 on 25 Feb 2026: can this oversold bounce hold

ByDanny Kontos February 25, 2026

The market closed with HNR1.SW stock at CHF 219.00, up 37.74% from the prior close on 25 Feb 2026. That strong move came on only 25 shares traded, a clear low‑liquidity bounce. The spike lifts Hannover Rück SE on the SIX in Switzerland but raises the question of sustainability. We examine valuation, fundamentals, sector context, and trigger levels for an oversold bounce trade.